|
Rilonacept Clinical Trials
1 actively recruiting trial across 1 location
Also known as: KPL-914
Pipeline
Phase 2: 1
Top Sponsors
- Mayo Clinic1
Indications
- Cardiac Sarcoidosis1
- Heart Disease1
Baltimore, Maryland1 trial
Rilonacept in Subjects With Cardiac Sarcoidosis
Johns Hopkins University
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.